ELISA: Direct: To detect hCTGFL/WISP-2 by direct ELISA (using 100 μL/well antibodysolution) a concentration of 0.25 - 1.0 μg/mL of this antibody is required. In conjunctionwith compatible secondary reagents, it allows the detection of at least 0.2 - 0.4 ng/well ofrecombinant hCTGFL/WISP-2. Sandwich: To detect hCTGFL/WISP-2 by sandwich ELISA (using 100 μL/well antibodysolution) a concentration of 0.25 - 1.0 μg/mL of this antibody is required. In conjunctionwith Polyclonal Anti-Human CTGFL/WISP-2 as a capture antibody, it allows the detection ofat least 0.2 - 0.4 ng/well of recombinant hCTGFL/WISP-2. Western Blot: To detect hCTGFL/WISP-2 by Western Blot analysis this antibody can be usedat a concentration of 0.1 - 0.2 μg/mL. Used in conjunction with compatible secondaryreagents the detection limit for recombinant hCTGFL/WISP-2 is 1.5 - 3.0 ng/lane, undereither reducing or non-reducing conditions. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Rekonstitution
Centrifuge vial prior to opening. Restore in sterile PBS containing 0.1 % BSA to a concentration of 0.1 - 1.0 mg/mL.
Buffer
PBS, pH 7.2
Handhabung
Avoid repeated freezing and thawing.
Lagerung
-20 °C
Informationen zur Lagerung
Store the lyophilized antibody at -20 °C. Following reconstitution it is stable for two weeks at 2 - 8 °C. Frozen aliquots are stable for 6 months when stored at -20 °C.
Haltbarkeit
6 months
Target
WISP2
(WNT1 Inducible Signaling Pathway Protein 2 (WISP2))